SIM
INFI

Strategic Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Strategic Investment Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,295
Closed -$95K – 124
2015
Q3 		$95K Sell
11,295
-4,648
-29% -$42.9K 0.04% 100
2015
Q2 		$174K Buy
15,943
+2,475
+18% +$31.8K 0.11% 94
2015
Q1 		$188K Hold
13,468
– – 0.07% 95
2014
Q4 		$227K Buy
+13,468
New +$196K 0.07% 61

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Strategic Investment Management's INFI Position: Q4 2015 in Review

Strategic Investment Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2015, closing a stake of 11,295 shares — an estimated $95K sold.

Strategic Investment Management first reported a position in INFI in Q4 2014 and held it in 4 quarters. The position peaked at $227K in Q4 2014. 115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

  • Strategic Investment Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Strategic Investment Management sold 11,295 Infinity Pharmaceuticals, Inc. shares in Q4 2015, an estimated $95K.
  • Strategic Investment Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
  • Strategic Investment Management's Infinity Pharmaceuticals, Inc. position peaked at $227K in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Strategic Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.